Form 8-K - Current report:
SEC Accession No. 0001558370-25-000100
Filing Date
2025-01-10
Accepted
2025-01-10 08:30:29
Documents
31
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtva-20250110x8k.htm   iXBRL 8-K 47405
2 EX-99.1 mtva-20250110xex99d1.htm EX-99.1 25403
3 GRAPHIC mtva-20250110x8k001.jpg GRAPHIC 9107
4 GRAPHIC mtva-20250110xex99d1g001.jpg GRAPHIC 103631
5 GRAPHIC mtva-20250110xex99d1g002.jpg GRAPHIC 198898
6 GRAPHIC mtva-20250110xex99d1g003.jpg GRAPHIC 162100
7 GRAPHIC mtva-20250110xex99d1g004.jpg GRAPHIC 98808
8 GRAPHIC mtva-20250110xex99d1g005.jpg GRAPHIC 198995
9 GRAPHIC mtva-20250110xex99d1g006.jpg GRAPHIC 39413
10 GRAPHIC mtva-20250110xex99d1g007.jpg GRAPHIC 187455
11 GRAPHIC mtva-20250110xex99d1g008.jpg GRAPHIC 37436
12 GRAPHIC mtva-20250110xex99d1g009.jpg GRAPHIC 135476
13 GRAPHIC mtva-20250110xex99d1g010.jpg GRAPHIC 90559
14 GRAPHIC mtva-20250110xex99d1g011.jpg GRAPHIC 131295
15 GRAPHIC mtva-20250110xex99d1g012.jpg GRAPHIC 107097
16 GRAPHIC mtva-20250110xex99d1g013.jpg GRAPHIC 90310
17 GRAPHIC mtva-20250110xex99d1g014.jpg GRAPHIC 67279
18 GRAPHIC mtva-20250110xex99d1g015.jpg GRAPHIC 98017
19 GRAPHIC mtva-20250110xex99d1g016.jpg GRAPHIC 106601
  Complete submission text file 0001558370-25-000100.txt   2725479

Data Files

Seq Description Document Type Size
20 EX-101.SCH mtva-20250110.xsd EX-101.SCH 3411
21 EX-101.LAB mtva-20250110_lab.xml EX-101.LAB 15927
22 EX-101.PRE mtva-20250110_pre.xml EX-101.PRE 10054
33 EXTRACTED XBRL INSTANCE DOCUMENT mtva-20250110x8k_htm.xml XML 4854
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 25520575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)